Wang et al. [46] reported that the PI3K/AKT/NF-κB signaling pathway plays a crucial role in lung ischemia–reperfusion injury, and [49] reported that the levels of activated NF-κB in COPD patients were significantly higher than those in normal individuals. Here, NFKB1 is linked to chronic obstructive pulmonary disease.